Pharmaceutical Executive Europe - November/December 2007 - (Page 31) Looking ahead with Evaluate Pharma® Valuation for the pharmaceutical and biotechnology sector Evaluate Pharma® can help When you need an estimate of the future value of products, pipelines, or entire companies, EvaluatePharma® can help with its winning combination of comprehensive industry data and an unrivalled analytical toolkit. EvaluatePharma® has been the leader in pharma consensus forecasts for over ten years. Today, we deliver unique insight into the past and future performance of the pharma and biotech sector in a user-friendly, online subscription service. Evaluate Pharma® delivers… product consensus forecasts compiled from the reports published by leading equity analysts historic sales data drawn from the most complete and reliable source of industry data – the reporting companies themselves in-depth company financials, with five year consensus forecasts market sizing and benchmarking by therapeutic category, technology, product sourcing (including licensing) etc. EvaluatePharma® – valuation for the pharma and biotech sector Contact us today to find out how Evaluate Pharma® can help you. Will Hau – Sales Director Europe e: willh@evaluategroup.com – t: +44 (0)7984 435 010 Evaluate Pharma® www.evaluatepharma.com http://www.evaluatepharma.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.